In March 2026, GeneDx Holdings Corp. announced a Niemann-Pick disease type C sponsored genetic testing program with Zevra Therapeutics, expanding access to ExomeDx at no cost for eligible U.S.
AIRO Group Holdings, Inc. recently presented at the 2026 Cantor Global Technology & Industrial Growth Conference at the New York Hilton Midtown, where Co-Founder & Executive Chairman Chirinjeev Baboo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results